The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study
Phase 4
- Conditions
- Renal disease
- Registration Number
- JPRN-UMIN000001611
- Lead Sponsor
- Graduate School of Medicine Science, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if patients had been malignant disease, previous upper abdominal surgery, neuropsychiatric disorder, organic brain damage, hepato-renal disorder, cardiopulmonary disorder, symptoms suggesting or were pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The current study attempted to compare the efficacy of rabeprazole with rebamipide after 12-week treatment in renal disease patients taking a oral steroid with or without H. pylori infections.
- Secondary Outcome Measures
Name Time Method Gastrointestinal symptom.(Gastrointesitinal Symptom Rating Scale) upper gastrointestinal endoscopy.